BlackRock’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,368,860
| Closed | -$387M | – | 5445 |
|
|
2020
Q4 | $387M | Buy |
5,368,860
+84,567
| +2% | +$4.43M | 0.01% | 1085 |
|
|
2020
Q3 | $241M | Sell |
5,284,293
-51,295
| -1% | -$2.14M | 0.01% | 1237 |
|
|
2020
Q2 | $241M | Buy |
5,335,588
+318,738
| +6% | +$14.3M | 0.01% | 1228 |
|
|
2020
Q1 | $193M | Sell |
5,016,850
-187,806
| -4% | -$8.65M | 0.01% | 1198 |
|
|
2019
Q4 | $241M | Buy |
5,204,656
+107,566
| +2% | +$4.66M | 0.01% | 1340 |
|
|
2019
Q3 | $208M | Buy |
5,097,090
+64,356
| +1% | +$2.78M | 0.01% | 1374 |
|
|
2019
Q2 | $242M | Buy |
5,032,734
+64,604
| +1% | +$3.4M | 0.01% | 1283 |
|
|
2019
Q1 | $311M | Sell |
4,968,130
-124,643
| -2% | -$8.56M | 0.01% | 1091 |
|
|
2018
Q4 | $304M | Buy |
5,092,773
+134,956
| +3% | +$8.1M | 0.02% | 997 |
|
|
2018
Q3 | $320M | Buy |
4,957,817
+360,529
| +8% | +$20.1M | 0.01% | 1123 |
|
|
2018
Q2 | $207M | Buy |
4,597,288
+339,306
| +8% | +$13.5M | 0.01% | 1430 |
|
|
2018
Q1 | $132M | Buy |
4,257,982
+164,145
| +4% | +$5.4M | 0.01% | 1648 |
|
|
2017
Q4 | $122M | Buy |
4,093,837
+281,415
| +7% | +$8.15M | 0.01% | 1736 |
|
|
2017
Q3 | $126M | Buy |
3,812,422
+247,543
| +7% | +$8.57M | 0.01% | 1693 |
|
|
2017
Q2 | $119M | Buy |
3,564,879
+55,767
| +2% | +$1.66M | 0.01% | 1688 |
|
|
2017
Q1 | $102M | Buy |
3,509,112
+3,504,035
| +69,018% | +$86.8M | 0.01% | 1764 |
|
|
2016
Q4 | $114K | Sell |
5,077
-2,430
| -32% | -$47.5K | ﹤0.01% | 2478 |
|
|
2016
Q3 | $140K | Sell |
7,507
-3,941
| -34% | -$74.3K | ﹤0.01% | 2394 |
|
|
2016
Q2 | $187K | Buy |
11,448
+10,001
| +691% | +$147K | ﹤0.01% | 2144 |
|
|
2016
Q1 | $17K | Buy |
1,447
+920
| +175% | +$10.3K | ﹤0.01% | 2942 |
|
|
2015
Q4 | $6K | Sell |
527
-700
| -57% | -$8.86K | ﹤0.01% | 3127 |
|
|
2015
Q3 | $15K | Buy |
1,227
+147
| +14% | +$1.87K | ﹤0.01% | 2565 |
|
|
2015
Q2 | $10K | Buy |
+1,080
| New | +$9.99K | ﹤0.01% | 2840 |
|
Other funds holding BEAT
BlackRock's BEAT Position: Q1 2021 in Review
BlackRock sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,368,860 shares — an estimated $387M sold.
BlackRock first reported a position in BEAT in Q2 2015 and held it in 23 quarters. The position peaked at $387M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- BlackRock reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- BlackRock sold 5,368,860 BioTelemetry, Inc. shares in Q1 2021, an estimated $387M.
- BlackRock first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 23 quarters.
- BlackRock's BioTelemetry, Inc. position peaked at $387M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.